65
41
Growth Score 65 in past quarter
-12 pts
Heat Score 41 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
335145
Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of
- Jane Royall: Director, Corporate Communications and Business PlanningPast Role: Center for Entrepreneurial Development, Development Manager, Membership
- David Wohde: Head of Digital TransformationPast Role: Acomodeo, Founder & COO
About the Company
Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of neurological and psychiatric diseases. Merz is leading in the field of Alzheimer's research and developed the world's first drug for the treatment of moderate to severe stages of Alzheimer's disease.
In the neurological sector, Merz also offers drugs for the treatment of Parkinson's, depression and dystonia.